Table 1 Baseline characteristics of the 302 patients
From: Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
Characteristic | |
|---|---|
Age, years | 69.6 ± 17.0a |
Male sex, no. (%) | 187 (61.9) |
Smoking status | |
Current smoker, no. (%) | 73 (24.2) |
Pack-years for smokers | 40.1 ± 24.2a |
Antibiotic pretreatment (%) | 61 (20.2) |
Coexisting illnesses, no. (%) | |
Coronary artery disease | 97 (32.1) |
Hypertensive heart disease | 78 (25.8) |
Congestive heart failure | 16 (5.3) |
Peripheral vascular disease | 20 (6.6) |
Cerebrovascular disease | 16 (5.3) |
Renal dysfunction | 81 (26.8) |
Liver disease | 31 (10.3) |
Diabetes mellitus | 61 (20.2) |
Chronic obstructive pulmonary disease | 76 (25.2) |
Neoplastic disease | 48 (15.9) |
History, no. (%) | |
Cough | 270 (89.4) |
Sputum | 221 (73.2) |
Dyspnea | 229 (75.8) |
Examination, no. (%) | |
Rales | 271 (89.7) |
Laboratory findings | |
CRP (mg/l), median (IQ range) | 129.7 [65–211] |
Procalcitonin (μg/l), median (IQ range) | 0.5 [0.2–2.2] |
Leukocyte count (× 109) | 13.6 ± 6.7a |
proADM (pmol/l), median (IQ range) | 1.1 [0.6–1.9] |
Radiographic findings, no. (%) | |
Pleural effusion | 37 (12.3) |
Multilobar CAP | 53 (17.5) |
PSI points | 99.4 ± 35.3a |
PSI class, no. (%) | |
I, II and III | 120 (39.7) |
IV | 130 (43) |
V | 52 (17) |